Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

July-August 2025 (Vol. 22 Issue 4) Table of Contents
Cancer Genomics - Proteomics: 22 (4)

Issue highlights

  • CRISPR/Cas9-mediated Knockout of LYVE1 In Human Tongue Cancer Cells Reveals Transcriptomic Changes in Metastasis-associated Pathways
  • Elevated Stanniocalcin-1 Expression in Uveal Melanoma Predicts Poor Patient Prognosis
  • C1orf50 Drives Malignant Melanoma Progression Through the Regulation of Stemness
  • Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility
  • Serum Proteomic Signatures of Pregnancy-associated Breast Cancer

 


 

New Special Issue on "​Transcriptomics: Identification of Fusion Transcripts; Non-coding RNAs; Discovery of New Transcripts - 2025"

Submission deadline: September 30, 2025;

Publication date: January 2026. ​

Click here for more information.

Featured Articles

  • Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human...
    September 04, 2017
  • The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan
    April 25, 2018
  • Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor...
    October 28, 2019
  • WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
    December 26, 2015
  • Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical...
    December 26, 2015
  • ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and...
    March 01, 2018

Latest Articles

  • Open Access
    C1orf50 Drives Malignant Melanoma Progression Through the Regulation of Stemness
    YUSUKE OTANI, MASAKI MAEKAWA, ATSUSHI TANAKA, TIRSO PEÑA, VANESSA D. CHIN, ANNA ROGACHEVSKAYA, SHINICHI TOYOOKA, MICHAEL H. ROEHRL and ATSUSHI FUJIMURA
    Cancer Genomics & Proteomics July 2025, 22 (4) 510-524; DOI: https://doi.org/10.21873/cgp.20518
  • Open Access
    CRISPR/Cas9-mediated Knockout of LYVE1 In Human Tongue Cancer Cells Reveals Transcriptomic Changes in Metastasis-associated Pathways
    SINI KARINEN, JOHANNA FORERO-RODRÍGUEZ, ANNIKA JÄRVINEN, KARI K. EKLUND, GONCALO BARRETO and ABDELHAKIM SALEM
    Cancer Genomics & Proteomics July 2025, 22 (4) 525-537; DOI: https://doi.org/10.21873/cgp.20519
  • Open Access
    Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility
    CHENG-HSI LIAO, WEN-SHIN CHANG, HOU-YU SHIH, YUN-CHI WANG, CHE-LUN HSU, SHU-YU CHANG, CHAO-HSIANG CHANG, WEN-CHI CHEN, DA-TIAN BAU and CHIA-WEN TSAI
    Cancer Genomics & Proteomics July 2025, 22 (4) 575-591; DOI: https://doi.org/10.21873/cgp.20523
  • Open Access
    CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms
    UMAR WAZIR, AMBER X. LI, CAROLYN CAI WANG, HENSON HAN GAO, TRACEY A. MARTIN, WEN G. JIANG and KEFAH MOKBEL
    Cancer Genomics & Proteomics July 2025, 22 (4) 557-563; DOI: https://doi.org/10.21873/cgp.20521
  • Open Access
    Serum Proteomic Signatures of Pregnancy-associated Breast Cancer
    ANNA-MARIA KORAKITI, ELENI ZOGRAFOS, STAVROS C. PROIKAKIS, ALKISTIS-MARIA PAPATHEODORIDI, KLEONIKI APOSTOLIDOU, CONSTANTINOS G. ZOGRAFOS, DIMITRIOS MANIATIS, CHRISTOS STEFANOU, SPYRIDON MARINOPOULOS, CONSTANTINE DIMITRAKAKIS, GRIGORIOS XEPAPADAKIS, GEORGE T. TSANGARIS, MELETIOS-ATHANASIOS DIMOPOULOS and FLORA ZAGOURI
    Cancer Genomics & Proteomics July 2025, 22 (4) 592-610; DOI: https://doi.org/10.21873/cgp.20524
  • Open Access
    High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer
    YUKA NAGASHIMA, KAZUNORI SASAKI, RYOSUKE CHIWAKI, HAYATO ISHII, KANA NOHATA, YUKI MAEMURA, TAKAHIRO KASAI, AYAKA OZAKI, SHOMA TAMORI, SHIGEO OHNO and KAZUNORI AKIMOTO
    Cancer Genomics & Proteomics July 2025, 22 (4) 538-556; DOI: https://doi.org/10.21873/cgp.20520
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile

Access CGP at your Mobile Device

Now you can access the entire contents of Cancer Genomics & Proteomics at your Android or iOS device with our newly designed mobile app, freely available through Google Play and App Store.

Visit the official website of Cancer Genomics & Proteomics.
Back to top
Cancer & Genome Proteomics

© 2025 Cancer Genomics & Proteomics

Powered by HighWire